Leadership Team

Mr. Barrett has almost 30 years of experience bringing new near-infrared light-based medical innovations to market. His career began in sales at Edwards Lifesciences. At Abbott Laboratories, he ran sales and marketing for the critical care business and was responsible for the Canadian Hospital Product’s Division. He has also served as CEO of Ornim Medical (Israel), and of Somanetics Corporation (Troy, MI) from early development until its sale to Covidien.

Dr. Hüttemann is Professor and Division Director for Research at the Center for Molecular Medicine & Genetics at Wayne State University School of Medicine. His research focus is mitochondrial bioenergetics- his work led to the discovery that discrete wavelengths of infrared light can positively modulate mitochondria of cells during the critical reperfusion period after an ischemic injury.

Dr. Sanderson is Associate Professor in the Department of Emergency Medicine and Molecular and Integrative Physiology at the University of Michigan. He serves as a grant reviewer for the NIH, DoD, and American Heart Association (AHA), and has received numerous research excellence awards from the AHA. His research focus is in cardiac arrest and resuscitation, translation of therapeutics, and mitochondrial dysfunction.

Mr. Waddell has over 30+ years of medical device project leadership. He currently serves as CEO of Waddell Group, a medical device project management consultancy, and has led over 40+ medical device projects from concept through launch in multiple medical markets.